Cargando…
Functional outcome of prolonged refractory status epilepticus
INTRODUCTION: To characterize etiology, clinical course and outcomes of patients in prolonged refractory status epilepticus (PRSE) and looking for prognostic factors. METHODS: Retrospective study conducted in patients hospitalized from January 1, 2001 to December 31, 2011 in 19 polyvalent intensive...
Autores principales: | , , , , , , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4426536/ https://www.ncbi.nlm.nih.gov/pubmed/25925042 http://dx.doi.org/10.1186/s13054-015-0914-9 |
_version_ | 1782370596066164736 |
---|---|
author | Lai, Alexandre Outin, Hervé D Jabot, Julien Mégarbane, Bruno Gaudry, Stéphane Coudroy, Rémi Louis, Guillaume Schneider, Francis Barbarot, Nicolas Roch, Antoine Lerolle, Nicolas Luis, David Fourrier, François Renault, Anne Argaud, Laurent Sharshar, Tarek Gibot, Sébastien Bollaert, Pierre-Edouard |
author_facet | Lai, Alexandre Outin, Hervé D Jabot, Julien Mégarbane, Bruno Gaudry, Stéphane Coudroy, Rémi Louis, Guillaume Schneider, Francis Barbarot, Nicolas Roch, Antoine Lerolle, Nicolas Luis, David Fourrier, François Renault, Anne Argaud, Laurent Sharshar, Tarek Gibot, Sébastien Bollaert, Pierre-Edouard |
author_sort | Lai, Alexandre |
collection | PubMed |
description | INTRODUCTION: To characterize etiology, clinical course and outcomes of patients in prolonged refractory status epilepticus (PRSE) and looking for prognostic factors. METHODS: Retrospective study conducted in patients hospitalized from January 1, 2001 to December 31, 2011 in 19 polyvalent intensive care units in French university and general hospitals. Patients were adults with a generalized convulsive refractory status epilepticus that lasted more than seven days, despite treatment including an anesthetic drug and mechanical ventilation. Patients with anoxic encephalopathy were excluded. Follow-up phone call was used to determine functional outcome using modified Rankin Scale (mRS) with mRS 0–3 defining good and mRS 4–6 poor outcome. RESULTS: 78 patients (35 female) were included. Median age was 57 years. Causes of status epilepticus were various, mainly including prior epilepsy (14.1%), CNS infection (12.8%), and stroke (12.8%). No etiology was found in 27 (34.6%) patients. PRSE was considered controlled in only 53 (67.9%) patients after a median duration of 17 (IQR 12–26) days. The median length of ICU stay was 28 (19–48) days. Forty-one (52.5%) patients died in the ICU, 26 from multiple organ failure, 8 from care withdrawal, 2 from sudden cardiac arrest, 1 from brain death and 4 from unknown causes. PRSE was previously resolved in 20 patients who died in the ICU. At one-year follow-up, there were 12 patients with good outcome and 58 with poor outcome and 8 lost of follow-up. On multivariate analysis, only vasopressor use was a predictor of poor outcome (OR 6.54; 95%CI 1.09-39.29; p = 0.04). CONCLUSION: Poor outcome was observed in about 80% of this population of PRSE. Most patients died from systemic complications linked to their ICU stay. Some patients can recover satisfactorily over time though we did not identify any robust factor of good outcome. |
format | Online Article Text |
id | pubmed-4426536 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2015 |
publisher | BioMed Central |
record_format | MEDLINE/PubMed |
spelling | pubmed-44265362015-05-12 Functional outcome of prolonged refractory status epilepticus Lai, Alexandre Outin, Hervé D Jabot, Julien Mégarbane, Bruno Gaudry, Stéphane Coudroy, Rémi Louis, Guillaume Schneider, Francis Barbarot, Nicolas Roch, Antoine Lerolle, Nicolas Luis, David Fourrier, François Renault, Anne Argaud, Laurent Sharshar, Tarek Gibot, Sébastien Bollaert, Pierre-Edouard Crit Care Research INTRODUCTION: To characterize etiology, clinical course and outcomes of patients in prolonged refractory status epilepticus (PRSE) and looking for prognostic factors. METHODS: Retrospective study conducted in patients hospitalized from January 1, 2001 to December 31, 2011 in 19 polyvalent intensive care units in French university and general hospitals. Patients were adults with a generalized convulsive refractory status epilepticus that lasted more than seven days, despite treatment including an anesthetic drug and mechanical ventilation. Patients with anoxic encephalopathy were excluded. Follow-up phone call was used to determine functional outcome using modified Rankin Scale (mRS) with mRS 0–3 defining good and mRS 4–6 poor outcome. RESULTS: 78 patients (35 female) were included. Median age was 57 years. Causes of status epilepticus were various, mainly including prior epilepsy (14.1%), CNS infection (12.8%), and stroke (12.8%). No etiology was found in 27 (34.6%) patients. PRSE was considered controlled in only 53 (67.9%) patients after a median duration of 17 (IQR 12–26) days. The median length of ICU stay was 28 (19–48) days. Forty-one (52.5%) patients died in the ICU, 26 from multiple organ failure, 8 from care withdrawal, 2 from sudden cardiac arrest, 1 from brain death and 4 from unknown causes. PRSE was previously resolved in 20 patients who died in the ICU. At one-year follow-up, there were 12 patients with good outcome and 58 with poor outcome and 8 lost of follow-up. On multivariate analysis, only vasopressor use was a predictor of poor outcome (OR 6.54; 95%CI 1.09-39.29; p = 0.04). CONCLUSION: Poor outcome was observed in about 80% of this population of PRSE. Most patients died from systemic complications linked to their ICU stay. Some patients can recover satisfactorily over time though we did not identify any robust factor of good outcome. BioMed Central 2015-04-30 2015 /pmc/articles/PMC4426536/ /pubmed/25925042 http://dx.doi.org/10.1186/s13054-015-0914-9 Text en © Lai et al.; licensee BioMed Central. 2015 This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly credited. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated. |
spellingShingle | Research Lai, Alexandre Outin, Hervé D Jabot, Julien Mégarbane, Bruno Gaudry, Stéphane Coudroy, Rémi Louis, Guillaume Schneider, Francis Barbarot, Nicolas Roch, Antoine Lerolle, Nicolas Luis, David Fourrier, François Renault, Anne Argaud, Laurent Sharshar, Tarek Gibot, Sébastien Bollaert, Pierre-Edouard Functional outcome of prolonged refractory status epilepticus |
title | Functional outcome of prolonged refractory status epilepticus |
title_full | Functional outcome of prolonged refractory status epilepticus |
title_fullStr | Functional outcome of prolonged refractory status epilepticus |
title_full_unstemmed | Functional outcome of prolonged refractory status epilepticus |
title_short | Functional outcome of prolonged refractory status epilepticus |
title_sort | functional outcome of prolonged refractory status epilepticus |
topic | Research |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4426536/ https://www.ncbi.nlm.nih.gov/pubmed/25925042 http://dx.doi.org/10.1186/s13054-015-0914-9 |
work_keys_str_mv | AT laialexandre functionaloutcomeofprolongedrefractorystatusepilepticus AT outinherved functionaloutcomeofprolongedrefractorystatusepilepticus AT jabotjulien functionaloutcomeofprolongedrefractorystatusepilepticus AT megarbanebruno functionaloutcomeofprolongedrefractorystatusepilepticus AT gaudrystephane functionaloutcomeofprolongedrefractorystatusepilepticus AT coudroyremi functionaloutcomeofprolongedrefractorystatusepilepticus AT louisguillaume functionaloutcomeofprolongedrefractorystatusepilepticus AT schneiderfrancis functionaloutcomeofprolongedrefractorystatusepilepticus AT barbarotnicolas functionaloutcomeofprolongedrefractorystatusepilepticus AT rochantoine functionaloutcomeofprolongedrefractorystatusepilepticus AT lerollenicolas functionaloutcomeofprolongedrefractorystatusepilepticus AT luisdavid functionaloutcomeofprolongedrefractorystatusepilepticus AT fourrierfrancois functionaloutcomeofprolongedrefractorystatusepilepticus AT renaultanne functionaloutcomeofprolongedrefractorystatusepilepticus AT argaudlaurent functionaloutcomeofprolongedrefractorystatusepilepticus AT sharshartarek functionaloutcomeofprolongedrefractorystatusepilepticus AT gibotsebastien functionaloutcomeofprolongedrefractorystatusepilepticus AT bollaertpierreedouard functionaloutcomeofprolongedrefractorystatusepilepticus |